Ethanolic extract of butea monosperma leaves elevate blood insulin level in type 2 diabetic rats, stimulate insulin secretion in isolated rat islets, and enhance hepatic glycogen formation

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Samad, Mehdi Bin ^a   Kabir, Ashraf Ul ^a   D'Costa, Ninadh Malrina ^a   Akhter, Farjana ^a   Ahmed, Arif ^a   Jahan, Mohammad Rajib ^a   Hannan, J M A ^a  

^a NORTH SOUTH UNIVERSITY   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIDIABETIC AGENT; BUTEA MONOSPERMA EXTRACT; CHOLESTEROL; GLIBENCLAMIDE; GLUCOSE; GLYCOGEN; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BODY MASS; BUTEA MONOSPERMA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ADSORPTION; DRUG EFFECT; DRUG ISOLATION; ENZYME ACTIVITY; FLUID INTAKE; FOOD INTAKE; GASTROINTESTINAL MOTILITY; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; GLYCOGEN LIVER LEVEL; GLYCOGEN METABOLISM; INSULIN BLOOD LEVEL; INSULIN RELEASE; LIPID BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET; PLANT LEAF; RAT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84899459578     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/356290     Document Type: Article

References (53)

1. Cockram C. S., The epidemiology of diabetes mellitus in the Asia-Pacific region. Hong Kong Medical Journal 2000 6 1 43 52 2-s2.0-0034150740
2. EURODIAB ACE Study Group, Variation and trends in incidence of childhood diabetes in Europe. The Lancet 2000 355 9207 873 876 2-s2.0-0034635768 10.1016/S0140-6736(99)07125-1
3. Aschner P., Diabetes trends in Latin America. Diabetes/Metabolism Research and Reviews 2002 18 3 S27 S31 2-s2.0-0036711340 10.1002/dmrr.280
4. Fagot-Campagna A., Pettitt D. J., Engelgau M. M., Ríos Burrows N., Geiss L. S., Valdez R., Beckles G. L. A., Saaddine J., Gregg E. W., Williamson D. F., Venkat Narayan K. M., Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. Journal of Pediatrics 2000 136 5 664 672 2-s2.0-0034035943
5. Huang E. S., Basu A., O'Grady M., Capretta J. C., Projecting the future diabetes population size and related costs for the U.S. Diabetes Care 2009 32 12 2225 2229 2-s2.0-70349207817 10.2337/dc09-0459
6. Yach D., Stuckler D., Brownell K. D., Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. World 2006 5 9.4 8
7. Hu F. B., Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011 34 6 1249 1257 2-s2.0-80051986265 10.2337/dc11-0442
8. Turner R. C., Cull C. A., Frighi V., Holman R. R., Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49). Journal of the American Medical Association 1999 281 21 2005 2012 2-s2.0-0032983666 10.1001/jama.281.21.2005
9. Krentz A. J., Bailey C. J., Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 2005 65 3 385 411 2-s2.0-13644263258 10.2165/00003495-200565030-00005
10. King H., Aubert R. E., Herman W. H., Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998 21 9 1414 1431 2-s2.0-0031752685
11. Ernst E., Prevalence of use of complementary/alternative medicine: a systematic review. Bulletin of the World Health Organization 2000 78 2 252 257 2-s2.0-0034058103
12. Ernst E., The role of complementary and alternative medicine. British Medical Journal 2000 321 7269 1133 1135 2-s2.0-0034605735
13. Somani R., Kasture S., Singhai A. K., Antidiabetic potential of Butea monosperma in rats. Fitoterapia 2006 77 2 86 90 2-s2.0-32344440152 10.1016/j.fitote.2005.11.003
14. Bavarva J. H., Narasimhacharya A. V. R. L., Preliminary study on antihyperglycemic and antihyperlipaemic effects of Butea monosperma in NIDDM rats. Fitoterapia 2008 79 5 328 331 2-s2.0-46449123592 10.1016/j.fitote.2008.02. 009
15. Sharma N., Garg V., Antihyperglycemic and antioxidative potential of hydroalcoholic extract of butea monosperma lam flowers in alloxan-induced diabetic mice. Indian Journal of Experimental Biology 2009 47 7 571 576 2-s2.0-70349326142
16. Panda S., Jafri M., Kar A., Meheta B. K., Thyroid inhibitory, antiperoxidative and hypoglycemic effects of stigmasterol isolated from Butea monosperma. Fitoterapia 2009 80 2 123 126 2-s2.0-60649114064 10.1016/j.fitote.2008.12.002
17. Sehrawat A., Sultana S., Chemoprevention by Butea monosperma of hepatic carcinogenesis and oxidative damage in male wistar rats. Asian Pacific Journal of Cancer Prevention 2006 7 1 140 148 2-s2.0-33745228128
18. Sharma N., Garg V., Antidiabetic and antioxidant potential of ethanolic extract of Butea monosperma leaves in alloxan-induced diabetic mice. Indian Journal of Biochemistry and Biophysics 2009 46 1 99 105 2-s2.0-65549136629
19. Gallagher A. M., Flatt P. R., Duffy G., Abdel-Wahab Y. H. A., The effects of traditional antidiabetic plants on in vitro glucose diffusion. Nutrition Research 2003 23 3 413 424 2-s2.0-0037361173 10.1016/S0271-5317(02)00533-X
20. Bayne K., Revised guide for the care and use of laboratory animals available. American physiological society. The Physiologist 1996 39 4 199 211 2-s2.0-0000582530
21. Lenzen S., The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008 51 2 216 226 2-s2.0-37549029242 10.1007/s00125-007- 0886-7
22. Moniruzzaman M., Rokeya B., Ahmed S., Bhowmik A., Khalil I., Gan S. H., In vitro antioxidant effects of Aloe barbadensis Miller extracts and the potential role of these extracts as antidiabetic and antilipidemic agents on streptozotocin-induced type 2 diabetic model rats. Molecules 2012 17 11 12851 12867
23. Trinder P., Enzymatic Colorimetric method for estimation of Glucose Test (GOD-PAP method), uric acid and phosohlipids. Annals of Clinical Biochemistry 1969 6 25
24. Moskalewski S., Studies on the culture and transplantation of isolated islets of langerhans of the guinea pig. Proceedings of the Koninklijke Nederlandse Akademie van Wetenschappen C 1969 72 2 157 171 2-s2.0-0014454143
25. van der Vies J., Two methods for the determination of glycogen in liver. The Biochemical Journal 1954 57 3 410 416 2-s2.0-77049178291
26. Swintosky J. V., Pogonowska-Wala E., The in-situ rat gut technique. Pharmacy International 1982 3 5 163 167 2-s2.0-0019995182
27. Hannan J. M. A., Ali L., Rokeya B., Khaleque J., Akhter M., Flatt P. R., Abdel-Wahab Y. H. A., Soluble dietary fibre fraction of Trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action. British Journal of Nutrition 2007 97 3 514 521 2-s2.0-34047254102 10.1017/S0007114507657869
28. Goto Y., Yamada K., Ohyama T., Matsuo T., Odaka H., Ikeda H., An -glucosidase inhibitor, AO-128, retards carbohydrate absorption in rats and humans. Diabetes Research and Clinical Practice 1995 28 2 81 87 2-s2.0-0029122656 10.1016/0168-8227(95)01065-L
29. Chatterjee T., Handbook of Laboratory Mice and Rats 1993 Kolkata, India Jadavpur University
30. Chau C.-F., Huang Y.-L., Lee M.-H., In vitro hypoglycemic effects of different insoluble fiber-rich fractions prepared from the peel of Citrus sinensis L. cv. Liucheng. Journal of Agricultural and Food Chemistry 2003 51 22 6623 6626 2-s2.0-0346363311 10.1021/jf034449y
31. Ou S., Kwok K.-C., Li Y., Fu L., In vitro study of possible role of dietary fiber in lowering postprandial serum glucose. Journal of Agricultural and Food Chemistry 2001 49 2 1026 1029 2-s2.0-0035111691 10.1021/jf000574n
32. Turner R., Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet 1998 352 9131 837 853 2-s2.0-0032511583 10.1016/S0140-6736(98)07019-6
33. Klein R., Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995 18 2 258 268 2-s2.0-0028944962
34. Williamson J. R., Chang K., Frangos M., Hasan K. S., Ido Y., Kawamura T., Nyengaard J. R., van den Enden M., Kilo C., Tilton R. G., Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993 42 6 801 813 2-s2.0-0027318772
35. Nesto R. W., Correlation between cardiovascular disease and diabetes mellitus: current concepts. The American Journal of Medicine 2004 116 5 11 22 2-s2.0-1542513468 10.1016/j.amjmed.2003.10.016
36. Hsueh W. A., Lyon C. J., Quiñones M. J., Insulin resistance and the endothelium. The American Journal of Medicine 2004 117 2 109 117 2-s2.0-3242695011 10.1016/j.amjmed.2004.02.042
37. Ginsberg H. N., Insulin resistance and cardiovascular disease. Journal of Clinical Investigation 2000 106 4 453 458 2-s2.0-0033860359
38. Siegel R. D., Cupples A., Schaefer E. J., Wilson P. W. F., Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study. Metabolism: Clinical and Experimental 1996 45 10 1267 1272 2-s2.0-0029840813 10.1016/S0026-0495(96)90246-2
39. Krauss R. M., Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 2004 27 6 1496 1504 2-s2.0-2542492541 10.2337/diacare.27.6.1496
40. Haffner S. M., Dyslipidemia management in adults with diabetes. Diabetes Care 2004 27 S68
41. Kawano K., Hirashima T., Mori S., Saitoh Y., Kurosumi M., Natori T., Spontaneous long-term hyperglycemic rat with diabetic complications: otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 1992 41 11 1422 1428 2-s2.0-0026722931
42. Schneider S., Feilen P. J., Schreckenberger M., Schwanstecher M., Schwanstecher C., Buchholz H. G., Thews O., Oberholzer K., Korobeynikov A., Bauman A., Comagic S., Piel M., Schirrmacher E., Shiue C. Y., Alavi A. A., Bartenstein P., Rösch F., Weber M. M., Klein H. H., Schirrmacher R., In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans. Experimental and Clinical Endocrinology and Diabetes 2005 113 7 388 395 2-s2.0-23044456342 10.1055/s-2005-865711
43. Guiot Y., Henquin J.-B., Rahier J., Effects of glibenclamide on pancreatic β -cell proliferation in vivo. European Journal of Pharmacology 1994 261 1-2 157 161 2-s2.0-0027978385 10.1016/0014-2999(94)90314-X
44. Jenkins D. J. A., Wolever T. M. S., Leeds A. R., Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. British Medical Journal 1978 1 6124 1392 1394 2-s2.0-0018142395
45. Groop P.-H., Aro A., Stenman S., Groop L., Long-term effects of guar gum in subjects with non-insulin-dependent diabetes mellitus. American Journal of Clinical Nutrition 1993 58 4 513 518 2-s2.0-0027381219
46. Edwards C. A., Johnson I. T., Read N. W., Do viscous polysaccharides slow absorption by inhibiting diffusion or convection? European Journal of Clinical Nutrition 1988 42 4 307 312 2-s2.0-0023912526
47. Burkitt D. P., Walker A. R., Painter N. S., Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease. The Lancet 1972 2 7792 1408 1412 2-s2.0-0015530176
48. Holgate A. M., Read N. W., Relationship between small bowel transit time and absorption of a solid meal. Influence of metoclopramide, magnesium sulfate, and lactulose. Digestive Diseases and Sciences 1983 28 9 812 819 2-s2.0-0020514832
49. Chiasson J.-L., Josse R. G., Gomis R., Hanefeld M., Karasik A., Laakso M., Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. The Lancet 2002 359 9323 2072 2077 2-s2.0-0037097039 10.1016/S0140-6736(02)08905-5
50. Chiasson J.-L., Josse R. G., Gomis R., Hanefeld M., Karasik A., Laakso M., Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. Journal of the American Medical Association 2003 290 4 486 494 2-s2.0-0038455703 10.1001/jama.290.4.486
51. Garvey W. T., Olefsky J. M., Griffin J., The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 1985 34 3 222 234 2-s2.0-0021990787
52. Pratley R. E., Weyer C., The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia 2001 44 8 929 945 2-s2.0-0034884627 10.1007/s001250100580
53. DeFronzo R. A., Gunnarsson R., Bjorkman O., Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. Journal of Clinical Investigation 1985 76 1 149 155 2-s2.0-0021994683